Department of Plastic and Reconstructive Surgery, Leeds Teaching Hospitals Trust, Leeds, United Kingdom.
Leeds Institute for Medical Research, University of Leeds, Leeds, United Kingdom.
JAMA Netw Open. 2020 Nov 2;3(11):e2024352. doi: 10.1001/jamanetworkopen.2020.24352.
Cubital tunnel syndrome is the second most common compressive neuropathy, affecting 6% of the population. Numerous different operations are performed globally to treat it; however, prior conventional (pairwise) meta-analyses have been unable to determine which procedure is associated with the best outcomes and fewest complications.
To evaluate which operation for cubital tunnel syndrome is associated with the greatest likelihood of symptomatic cure.
PubMed, EMBASE, and CENTRAL were searched from database inception to March 2, 2019, with no restrictions on the setting or design of studies.
Experimental and observational studies directly comparing the outcomes of at least 2 surgical treatments for adults with primary cubital tunnel syndrome were included. Case reports were excluded, and when comparative studies had subgroups with 1 participant, the single-participant subgroup was excluded. The treatments had to be in situ decompression with or without medial epicondylectomy or an anterior subcutaneous, subfascial, intramuscular, or submuscular transposition. The access could be open, minimally invasive, or endoscopic. The comparator could be sham surgery or any operation mentioned earlier.
Data were extracted by 2 independent reviewers, following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline and the PRISMA Network Meta-analysis extension statement. Network meta-analysis was used to estimate the relative efficacy and safety associated with interventions using relative risks. Surgical techniques were ranked by their probability of being the best (P score) and interpreted in terms of their clinical impact.
The primary outcome was response to treatment (ie, symptomatic improvement). The secondary outcomes were perioperative complications, reoperation, and recurrence.
A total of 30 studies of 2894 limbs undergoing 8 different operations were included. Across the studies, 56% of participants were men, the mean (SD) age was 48 (8) years, and patients had symptoms for a mean (SD) of 15 (7) months. Overall, 87% (95% CI, 92%-91%) of patients improved with surgery; all forms of in situ decompression were more effective than any type of transposition procedure; for example, open in situ decompression with epicondylectomy was associated with higher success rates than subcutaneous transposition (relative risk, 1.13; 95% CI, 1.01-1.25). Postoperatively, 3% (95% CI, 2%-4%) of patients developed complications, and in situ decompressions were ranked as the least risky, although there was considerable uncertainty in this outcome. Overall, 2% (95% CI, 1%-3%) of patients required reoperation; open in situ decompression was associated with the fewest reoperations; in comparison, submuscular transposition was associated with 5 times the risk of reoperation (relative risk, 5.08; 95% CI, 2.06-12.52). During surveillance, 3% (95% CI, 1%-4%) of patients developed recurrence, and open in situ decompression with epicondylectomy was ranked as the safest operation, although there was uncertainty in the estimates.
In this network meta-analysis, open in situ decompression (with or without medial epicondylectomy) appeared to be the safest operation and also was associated with the best outcomes for patients with primary cubital tunnel syndrome. Future research should focus on better defining this disorder and developing core outcome measures.
尺管综合征是第二常见的压迫性神经病,影响 6%的人口。全球有许多不同的手术用于治疗它;然而,之前的传统(成对)荟萃分析无法确定哪种手术与最佳结果和最少并发症相关。
评估治疗尺管综合征的哪种手术最有可能治愈症状。
从数据库建立到 2019 年 3 月 2 日,在没有对研究设置或设计限制的情况下,在 PubMed、EMBASE 和 CENTRAL 上进行了搜索。
直接比较至少 2 种手术治疗成人原发性尺管综合征结果的实验和观察性研究包括在内。排除病例报告,当比较研究有 1 个参与者的亚组时,排除了单个参与者的亚组。治疗必须是原位减压,伴或不伴内侧肘切除术或前皮下、筋膜下、肌内或肌下转位。进入途径可以是开放的、微创的或内窥镜的。比较器可以是假手术或前面提到的任何手术。
两名独立审查员按照系统评价和荟萃分析的首选报告项目(PRISMA)报告准则和 PRISMA 网络荟萃分析扩展声明提取数据。使用相对风险估计干预措施的相对疗效和安全性,并使用网络荟萃分析。根据其成为最佳操作(P 评分)的概率对手术技术进行排名,并根据其临床影响进行解释。
主要结果是治疗反应(即症状改善)。次要结果是围手术期并发症、再次手术和复发。
共纳入了 30 项研究,涉及 2894 条肢体的 8 种不同手术。在这些研究中,56%的参与者为男性,平均(SD)年龄为 48(8)岁,患者的症状平均(SD)为 15(7)个月。总体而言,87%(95%CI,92%-91%)的患者通过手术得到改善;所有形式的原位减压均比任何类型的转位手术更有效;例如,开放式原位减压伴肘切除术与皮下转位(相对风险,1.13;95%CI,1.01-1.25)相比,成功率更高。术后,3%(95%CI,2%-4%)的患者发生并发症,原位减压被认为风险最低,尽管这一结果存在很大的不确定性。总体而言,2%(95%CI,1%-3%)的患者需要再次手术;开放式原位减压与最少的再手术相关;相比之下,肌下转位与再手术的风险增加 5 倍(相对风险,5.08;95%CI,2.06-12.52)。在监测期间,3%(95%CI,1%-4%)的患者出现复发,开放式原位减压伴肘切除术被认为是最安全的手术,尽管估计存在不确定性。
在这项网络荟萃分析中,开放式原位减压(伴或不伴内侧肘切除术)似乎是最安全的手术,也与原发性尺管综合征患者的最佳结果相关。未来的研究应集中于更好地定义这种疾病,并制定核心结果测量。